ImprimisRx to Introduce New Formulations at Cataract & Refractive Surgery Annual Meeting
30 avr. 2019 07h00 HE
|
Harrow Health, Inc.
SAN DIEGO, April 30, 2019 (GLOBE NEWSWIRE) -- ImprimisRx, the ophthalmology-focused pharmaceutical compounding subsidiary of Harrow Health, Inc. (NASDAQ: HROW), today announced its participation at...